Last reviewed · How we verify

NCT05538468

Kinesiophobia in Stroke Patients and Affecting Factors

Completed Last updated 13 September 2022
What this trial tests

trial testing Assessment in Kinesiophobia in 30 participants. Completed in 30 July 2019.

Timeline
10 February 2019
Primary endpoint
15 July 2019
30 July 2019

Quick facts

Lead sponsorInonu University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date10 February 2019
Primary completion15 July 2019
Estimated completion30 July 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 25 to 70, any sex, with Kinesiophobia or Stroke Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was aimed to determine the presence of kinesiophobia that will affect the treatment in stroke patients and to investigate the relationship between these factors and kinesiophobia by examining factors such as postural control, depression, pain, and affected side that may cause kinesiophobia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Assessment

Trials testing the same drug.

Other recruiting trials for Kinesiophobia

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05538468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing